Skip to content
Friday, October 23, 2026 · Today’s edition, 6:30 a.m. ETFri, Oct 23 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
AnalysisInsuranceThe WrapThe Insurance Capital Week

Strategics are taking insurance control, and sponsors are the sellers

Samsung's move toward 90% of Canopius, JAB's Columbian conversion, and Corebridge-Equitable's cleared merger all point one way: permanence is the premium.

At a glance

  1. Canopius arrives at the same destination from the other end: a strategic that starts with a minority position and finishes near 90% has bought optionality first and control second, and it has done so without the auction a sponsor-to-sponsor sale would have required.
  2. The detail that the stake stops short of 100% is worth keeping: ninety percent delivers control — the board, the underwriting appetite, the capital allocation, the reserving philosophy — while leaving a sliver outstanding that keeps any remaining minority aligned without the price of a full take-private.
  3. Centerbridge's reward is a clean exit, and a clean exit at a good price is what the sponsor model is ultimately selling; there is nothing fragile about the trade on its own, since the sponsor takes the platform risk, the strategic takes the franchise, and each is paid for what it is good at.

Samsung's insurance affiliates have reportedly agreed to buy another 50% of Canopius, a purchase that would lift the Korean group's stake in the Lloyd's specialty insurer toward 90% and hand Centerbridge Partners the exit that sponsor capital is built to find, which makes it the week's clearest evidence of the direction insurance M&A has taken: the strategics are the buyers, and the sponsors are the sellers.

That reverses the sequence that defined the last cycle, when sponsors spent a decade accumulating minority stakes in insurers and Lloyd's platforms, holding them through turnarounds, and selling to a strategic once the book was clean. Canopius arrives at the same destination from the other end: a strategic that starts with a minority position and finishes near 90% has bought optionality first and control second, and it has done so without the auction a sponsor-to-sponsor sale would have required.

The detail that the stake stops short of 100% is worth keeping: ninety percent delivers control — the board, the underwriting appetite, the capital allocation, the reserving philosophy — while leaving a sliver outstanding that keeps any remaining minority aligned without the price of a full take-private. The reported shape shows a buyer that wants the steering wheel without necessarily paying for every last share.

For a strategic, a Lloyd's platform is a particular kind of asset: the syndicate capacity, the market access and the licenses are slow to build and quick to buy, which makes control a way to own underwriting capability rather than rent it, and a stronger reason to pay for 90% than the returns on a minority stake ever handed a sponsor.

Centerbridge's reward is a clean exit, and a clean exit at a good price is what the sponsor model is ultimately selling; there is nothing fragile about the trade on its own, since the sponsor takes the platform risk, the strategic takes the franchise, and each is paid for what it is good at. What matters for the wider market is who is left to buy when the sponsors want out, and the week supplied two more answers.

Sponsors have been the industry's patient minority capital for years, and for good reason: insurance books reward a long hold, reserves develop slowly, and a turnaround that looks promising in year two can take five to season, a return the public market rarely prices in. The catch is that the sponsor's return only exists if somebody eventually buys the seasoned asset — another sponsor, an offering, or, increasingly, a strategic that wants control.

A mutual crosses the line

JAB closed its rescue of Columbian by converting the 144-year-old mutual into a stock company, ending the insurer's stay in rehabilitation and placing it under the permanent capital of a family-backed holding company, and the structure is the point: a mutual has no shareholders to dilute and no sponsor to repay; its capital comes from policyholders and retained earnings, and rehabilitation is the process that begins when that capital is gone. Converting to stock and selling to an owner that does not need to exit is the route back, and it hands regulators a template for the next case.

That template answers a question supervisors have been circling for years: what becomes of a failing mutual when no sponsor will take it and no public offering is available? The answer is a buyer whose capital can sit with the book indefinitely, and JAB's holding-company model, built on long-duration money that is not under pressure to return it, is what the final stage of a rehabilitation requires, when the objective is stability rather than a fast resale.

The distinction from a sponsor is the clock: a sponsor buys in order to sell, which puts a horizon on every decision it makes — how much to invest, how long to carry a troubled book, when to push for a sale — while a permanent-capital owner buys in order to keep, and the holding discipline that follows is a different discipline from an exit discipline. For a mutual emerging from rehabilitation, with policyholders who expect the promises to hold, that difference is the whole transaction.

Whether the model becomes a channel or a one-off depends on how many mutuals land in the same position, and the 144 years matter less as trivia than as a reminder of what these franchises are: institutions whose promises outlast any single owner. A stock conversion is the mechanism; the permanent capital behind it is what makes the promise creditable.

Reported by The Wrap desk from PWD editorial brief and PWD weekly data pack — insurance capital. Published . Corrections

Private Wealth Daily member access

Continue this analysis

Get the complete Insurance analysis and every detail that follows.

Enter a valid work email to continue reading.

Insurance Capital Daily, from Private Wealth Daily. Unsubscribe anytime.

Full featuresIn-depth analysis and exclusive reporting.
Source-backed contextEvidence, context and the complete story.
One login across the networkAccess every Daily Network publication.

Related

Insurance

Samsung's China unit keeps its A as the group buys control

The affirmation is continuity on a small China unit. The credit question is how Samsung funds the Canopius control stake.

Insurance

Samsung insurers move on Canopius control

The reported purchase of another 50% would push the Korean duo toward 90% control and hand Centerbridge Partners an exit, at a moment when strategics and public balance sheets are doing the buying.

Insurance

The calm that builds the next wave

Reinsurance is loosening terms, not just price, and the failure record says the quiet is when solvency erodes.

Insurance

AM Best affirms A rating on Aramco captive Stellar

Balance-sheet strength is assessed as very strong, with three-quarters of assets in a parent promissory note.

Insurance

DOXA Re launches property quota-share MGU with James Femia as president

The managing general underwriter has not disclosed capacity providers, property lines or premium targets.

From other sections